Next Article in Journal
A One-Health Model for Reversing Honeybee (Apis mellifera L.) Decline
Previous Article in Journal
Molecular and Serological Footprints of Mycobacterium avium Subspecies Infections in Zoo Animals
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats

1
Department of Biomedical Sciences, School of Veterinary Medicine, Ross University, Basseterre 00265, Saint Kitts and Nevis
2
Rabies Laboratory, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66505, USA
3
Bacteriology and Avian Diseases, Department of Pathology, Faculty of Veterinary Medicine, Ghent University, Ghent 9000, Belgium
*
Author to whom correspondence should be addressed.
Vet. Sci. 2020, 7(3), 118; https://doi.org/10.3390/vetsci7030118
Submission received: 24 July 2020 / Revised: 18 August 2020 / Accepted: 20 August 2020 / Published: 26 August 2020
(This article belongs to the Section Veterinary Microbiology, Parasitology and Immunology)

Abstract

:
β-glucans have been shown to stimulate the immune system in several animal species. The aim of this study was to evaluate the immune stimulation capacity of a fully formulated diet with β-1,3-1,6-glucans in cats, by assessing the rabies antibody titer after vaccination. Thirty-five healthy cats were recruited. The cats were placed into two groups and fed a standard diet in accordance with body weight. One group had the β-glucans incorporated into the diet; the other group served as the control group. After two weeks of dietary adjustment; the rabies vaccine (Imrab® 3 TF; Merial) was administered on days 0 and 21. Blood samples were taken on days 0, 21, and 42. Titers were determined with the rapid fluorescent foci inhibition test (RFFIT). Titers at days 21 and 42 were compared between the two groups in a linear mixed effects model. This study showed that the animals receiving the non-supplemented feed had higher post-vaccination rabies antibody titers. This indicates that, in contrast to other animal species, the β-glucan supplemented diet did not have the expected positive effect on the rabies antibody titers in cats.

1. Introduction

Prebiotics are food ingredients that exert beneficial effects by altering the metabolism in the intestinal tract [1]. β-1,3-1,6-glucans, derived from the yeast cell wall of Saccharomyces cerevisiae fall into this category. When extracted from the cell wall of fungi, these polysaccharides can also work as immunomodulators, by boosting the host’s immune response to antigens in many immuno-therapies [2]. β-glucans have important effects on the immune response. Working through the gut-associated lymphoid tissue (GALT), β-glucans will bind to the transmembrane protein receptors, TLR2/TLR6 (Toll-like receptors), and dectin-1 on dendritic cells, follicular dendritic cells, macrophages, and even B-cells [3,4]. β-1,3-1,6-glucans enhance innate immune cellular abundance and function. Through the primary stimulus of β-1,3-1,6-glucans, there will be an increased abundance of antigen-specific lymphocytes that result in an increased innate immune response, as well as an increase in humoral and cellular immune response after vaccination [5,6].
Previous studies in dogs [7], mice [8], and pigs [9,10] have demonstrated that β-1,3-1,6-glucans produce an increase in the immunological response to rabies vaccination. There are no such data available for cats, therefore, we investigated the effect of β-1,3-1,6-glucans, added to a balanced cat diet, on rabies antibody titers following rabies vaccination.

2. Materials and Methods

2.1. Animals

The animal trial was approved by the RUSVM IACUC under number 19.05.18.
Thirty-six cats were recruited from owners, mainly veterinary students, who signed an informed consent document. Cats underwent a health check before inclusion and were housed with their owners. The exclusion criteria were as follows: kittens younger than 3 months, visibly old cats/cats older than 10 years, cats with poor body condition, and seropositive rabies antibody tested cats. Cats were to be housed inside for the entire study to increase control over the diet. One cat was withdrawn from the study at the owner’s request.

2.2. Study Design

This was an owner- and investigator-blinded study. The vaccination date was taken as day 0. On day 21, a 1 mL blood sample was collected for determination of the presence of rabies antibodies. The BioPro ELISA test was used as the initial screening test (day 21 sample) to demonstrate that the animals were serologically negative for rabies antibodies. The BioPro ELISA test was executed according to the instructions of the manufacturer [11]. Cats’ age, sex, and weight were also determined on day-21. Prior to day 14, the rabies antibody negative animals were allocated to two groups. Subjects in Group A were given a diet without β-1,3-1,6-glucans (control group) and subjects in Group B were given the same diet supplemented with β-1,3-1,6-glucans (test group). The cats were assigned to a group based on a similar distribution of age and sex. The change in diet for both groups began fourteen days before vaccination. On day 0, a 3 mL blood sample was taken for baseline rabies virus neutralizing antibody (RVNA) titers, after which the animals were vaccinated with rabies vaccine (Imrab® 3 TF, Merial, Lyon, France). All blood samples were refrigerated for 24 h, then centrifuged at 2500 rpm for 10 min, after which serum was collected, placed into pre-labeled tubes, and stored at −80 °C. On day 21, a new 3 mL blood sample was taken for RVNA titer determination, after which the animals received a booster vaccination to increase the titers, to better see an immunological response. The trial ended on day 42 with a final 3 mL blood draw for endpoint RVNA titers. RVNA titers in sera at days 0, 21 and 42 were determined by the rapid fluorescent focus inhibition test (RFFIT), performed at the Kansas State University Rabies Laboratory [12].

2.3. Statistical Analysis

We used R [13] and the lme4 package [14] to perform a linear mixed effects analysis of the relationship between post-vaccination RVNA titers and diet. As fixed effects, we entered diet (group A vs. group B) and time (days 21 and 42) into the model. As random effects, we had intercepts for subjects. A visual inspection of residual plots did not reveal any obvious deviations from homoscedasticity or normality. p-Values were obtained by likelihood ratio tests of the full model with the effect in question against the model without the effect in question.

3. Results

Thirty-six cats were enrolled in this study. Thirty-five cats were screened at day 21 with the BioPro ELISA Rabies AB+ Kit; one cat was withdrawn from the trial prior to initial ELISA test at the owner’s request. Group A was comprised of 18 cats (9 males and 9 females), while Group B contained 17 cats (9 males and 8 females), as shown in Table 1. The average weight for Groups A and B were 3.75 kg and 3.72 kg, respectively. The average ages of Groups A and B were 13.2 months and 14.2 months, respectively.
All 35 of the cats tested negative for rabies antibodies, and thus all were eligible for the study. RVNA titer results taken from sera at day 0 showed that all cats had titers ≤0.1 IU/mL. The RVNA levels ranged from 13.10–131 IU/mL in group A, and from 3.3–131 IU/mL in group B. The geometric mean concentration (± standard error) at day 21 was 15.5 ± 2.7 IU/mL for group A and 6.6 ± 2.9 IU/mL for group B. The geometric mean concentration at day 42 was 36.6 ± 1.9 IU/mL for group A and 23.5 ± 2.4 IU/mL for group B. Figure 1 shows the log-transformed RVNA levels by diet group and time. The interaction between diet and time was not statistically significant (ꭓ2 (1) = 1.50, p = 0.22). Diet affected RVNA levels (ꭓ2 (1) = 6.24, p = 0.012), with levels of cats in Group B lower by an estimated 1.9 IU/mL ± 1.3. In an exploratory analysis, the effect of sex was not statistically significant (ꭓ2 (1) = 1.09, p = 0.30). All cats (irrespective of diet) showed an adequate serological response to rabies vaccine.

4. Discussion

Studies in dogs [7], mice [8], pigs [9,10], horses [15] and various other species, including fish [16,17] and invertebrates [18], have demonstrated that β-1,3-1,6-glucans, derived from the yeast cell wall of Saccharomyces cerevisiae, produce an increase in the immunological response to foreign antigens. In our study, although both groups of cats developed an adequate neutralizing antibody response to a primary and booster injection of the rabies vaccine, the response was lower in cats that were fed a diet supplemented with β-1,3-1,6-glucans, compared with cats that were fed an un-supplemented diet, contrary to what was seen in other species.
A major pathway through which β-1,3-1,6-glucans stimulate and prime the immune system is through the dectin-1 surface protein in conjunction with TLR 2/TLR 6. This pathway has been shown to cause a change in CD45+, CD8+, and CD4+ T-cells, in the mesenteric lymph nodes, as well as the Peyer’s patches [19]. The stimulation by β-glucans has been shown to have a significant increase in the production of IL-12, IL-6, and TNF-α [20]. These pro-inflammatory cytokines aid in the production and proliferation of Th-1, Th-2, NK-cells, B-cells, and the production of immunoglobulins by plasma cells [21]. Although in most species these pathways support the immune stimulation, it did not support the same effect in cats. Studies in dogs have shown that both the cell-mediated and humoral responses of the innate and adaptive immune system were beneficially affected by the introduction of β-glucans [7,22]. While dogs and cats share similar immunological pathways and mechanisms [23], there is no clear explanation as to why there was not a similar response in cats.
One clear difference between the immunology of cats and dogs is the presence of the genes encoding the major histocompatibility complex (MHC). The genetic makeup of dogs’ MHC II, unlike that of cats, has been shown to have all three of the genes enabling proper antigen presentation. The dog leukocyte antigen complex (DLA) genes for MHC II are made up of DLA-DP-DQ-DR; in contrast, the feline leukocyte antigen complex (FLA), which is made up of FLA-DP-DR, shows a severe decrease in the function of the DP, which may explain an increased susceptibility to autoimmune disorders in felines [24]. It could be that the already naturally hindered pathway taken from MHC II to the CD4+ cells to eventually induce an antibody response in cats, may be interrupted by the introduction of β-1,3-1,6-glucans. With the increase of IL-12 and TNFα, β-glucans may cause an epigenetic shift that favors the production of proinflammatory cytokines as well as natural killer cells, as opposed to other species showing increases in antibody response. Further research looking at the cytokines produced, and the level at which they are produced, will help explain what pathways are favored depending on the presence or absence of β-1,3-1,6-glucans in the diet of cats.
Our knowledge of the intestinal bacterial microbiome of both dogs and cats is evolving rapidly, and it has been shown that the intestinal microbiome of cats is much more diverse than the microbial communities in the intestine of dogs [25,26]. The diversity between cats is however smaller than that of the diversity between dogs. Though both species are carnivores, capable of eating meat and plants, the narrow food requirements of cats as obligate carnivores require more precision in the formulation of its diets, relative to the more omnivorous dogs [27]. It was postulated that Saccharomyces is not an indigenous organism in any species’ intestinal microbiota, but rather, is found only after nutritional consumption [28]. Saccharomyces species are, however, found in large quantities in the intestinal microbiome of cats, and this may be an indication as to why the β-1,3-1,6-glucans, derived from the yeast cell wall of Saccharomyces cerevisiae, have had a different effect compared to what is seen in other animal species. The supplementation with extra β-glucans, resulting in even higher levels of β-glucans, might be a reason for why the β-1,3-1,6-glucan supplemented diet had a different effect. Further investigation of the intestinal microbiome of cats, the effects of Saccharomyces in conjunction with S. cerevisiae derived β-1,3-1,6-glucan on the gut associated lymphoid tissue, and the overall feline immune system is needed.
Though this study was not designed to detect the differences between sex, we noticed (though not significant because of the small sample size) a difference between male and female cats. It is unclear whether there could be an immunological mechanism, more strongly associated with female cats, that could cause a rabies antibody suppression after the oral supplementation of β-glucans. Previous research showed a difference in immunological response to antigens based on sex in other species [29,30,31,32,33]. There are indications that testosterone, androgen, and estrogen levels in any species have immunological regulating capacities [34,35,36]. Repeating the study with a higher number of animals may bring clarity in this potential difference.

5. Conclusions

In contrast to other animal species, the β-1,3-1,6-glucan supplemented diet did not give the same effect on anti-rabies antibodies in cats. While in other animal species, the β-1,3-1,6-glucans showed significantly higher antibody titers than the non-supplemented feed, in cats, it was the inverse. The reasons for this remain unclear and need further investigation.

Author Contributions

Conceptualization, P.B.; methodology, J.B., D.K., and P.B.; investigation, J.B., D.K., and P.B.; data curation, J.B., D.K., S.M.M. and S.G. for RVNA titer, and P.B.; writing—original draft preparation, J.B., D.K., and P.B.; writing—review and editing, J.B., D.K., S.M.M., S.G. and P.B.; supervision, D.K., and P.B.; funding acquisition, P.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received external funding from a company.

Acknowledgments

We thank the DVM students at Ross University School of Veterinary Medicine for signing up their cats, following the guidelines, and participating in this study, and the Ross University Veterinary Clinic for their help in training and providing the facilities to carry out this project. We are grateful to E. Mawhinney and G. Sprowls for their help in sampling for this project, S. Marchi for her aid in the ELISA testing protocol, and L. Dzikiti for advice on the statistical analysis.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

DLADog Leukocyte Antigen Complex
FLAFeline Leukocyte Antigen Complex
GALTGut-Associated Lymphoid Tissue
MHCMajor Histocompatibility Complex
TLRToll-Like Receptors
RFFITRapid Florescent Foci Inhibition Test
RVNA Rabies Virus Neutralizing Antibody

References

  1. Gibson, G.; Scott, K.; Rastall, R.; Tuohy, K.; Hotchkiss, A.; Dubert-Ferrandon, A.; Gareau, M.; Murphy, E.F.; Saulnier, D.; Loh, G.; et al. Dietary prebiotics: Current status and new definition. Food Sci. Technol. Bull. Funct. Foods 2010, 7, 1–19. [Google Scholar] [CrossRef] [Green Version]
  2. Hong, F.; Hansen, R.D.; Yan, J.; Allendorf, D.J.; Baran, J.T.; Ostroff, G.R.; Ross, G.D. β-Glucan Functions as an Adjuvant for Monoclonal Antibody Immunotherapy by Recruiting Tumoricidal Granulocytes as Killer Cells. Am. Assoc. Cancer Res. 2003, 63, 9023–9031. [Google Scholar]
  3. Brown, G.D.; Taylor, P.R.; Reid, D.M.; Willment, J.A.; Williams, D.L.; Martinez-Pomares, L.; Wong, S.Y.C.; Gordon, S. Dectin-1 is a Major β-Glucan Receptor on Macrophages. J. Exp. Med. 2002, 196, 407–412. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Han, B.; Baruah, K.; Cox, E.; Vanrompay, D.; Bossier, P. Structure-Functional Activity Relationship of b-Glucans From the Perspective of Immunomodulation: A Mini-Review. Front. Immunol. 2020, 11. [Google Scholar] [CrossRef] [Green Version]
  5. Netea, M.G.; Joosten, L.A.; Latz, E.; Mills, K.H.; Natoli, G.; Stunnenberg, H.G.; O’Neill, L.A.; Xavier, R.J. Trained immunity: A program of innate immune memory in health and disease. Science 2016, 352. [Google Scholar] [CrossRef] [Green Version]
  6. Marakalala, M.J.; Williams, D.L.; Hoving, J.C.; Engstad, R.; Netea, M.G.; Brown, G.D. Dectin-1 plays a redundant role in the immunomodulatory activities of b-glucan-rich ligands in vivo. Microbes Infect. 2013, 15, 511–515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Vojtek, B.; Mojžišová, J.; Smrčo, P.; Drážovská, M. Effects of orally administered β–1,3/1,6–glucan on vaccination responses and immunological parameters in dogs. Food Agric. Immunol. 2017, 28, 993–1002. [Google Scholar] [CrossRef] [Green Version]
  8. Hetland, G.; Sandven, P. β-1,3-glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures. FEMS Immunol. Med. Microbiol. 2002, 33, 41–45. [Google Scholar] [CrossRef]
  9. Stuyven, E.; Cox, E.; Vancaeneghem, S.; Arnouts, S.; Deprez, P.; Goddeeris, B.M. Effect of β-glucans on an ETEC infection in piglets. Vet. Immunol. Immunopathol. 2009, 128, 60–66. [Google Scholar] [CrossRef] [PubMed]
  10. Vetvicka, V.; Vannucci, L.; Sima, P. The Effects of β-Glucan on Pig Growth and Immunity. Open Biochem. J. 2014, 8, 89–93. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Procedure. Available online: https://www.rabieselisa.com/procedure/ (accessed on 4 September 2019).
  12. Rupprecht, C.E.; Fooks, A.R.; Abela-Ridder, B. Laboratory Techniques in Rabies, 15th ed.; World Health Organization: Geneva, Switzerland, 2018; Available online: https://apps.who.int/iris/bitstream/handle/10665/310836/9789241515153-eng.pdf?ua=1 (accessed on 8 July 2020).
  13. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2020; Available online: https://www.R-project.org/ (accessed on 5 May 2020).
  14. Bates, D.; Maechler, M.; Bolker, B.; Walker, S. Fitting Linear Mixed-Effects Models Using lme4. J. Stat. Softw. 2015, 67, 1–48. [Google Scholar] [CrossRef]
  15. Krakowski, L.; Krzyzanowski, J.; Wrona, Z.; Siwicki, A.K. The effect of nonspecific immunostimulation of pregnant mares with 1,3/1,6 glucan and levamisole on the immunoglobulins levels in colostrum, selected indices of nonspecific cellular and humoral immunity in foals in neonatal and postnatal period. Vet. Immunol. Immunopathol. 1999, 68, 1–11. [Google Scholar] [CrossRef]
  16. Ai, Q.; Mai, K.; Zhang, L.; Tan, B.; Zhang, W.; Xu, W.; Li, H. Effects of dietary β-1 3-glucan on innate immune response of large yellow croaker, Pseudosciaena crocea. Fish. Shellfish Immunol. 2007, 22, 394–402. [Google Scholar] [CrossRef] [PubMed]
  17. Selim, K.M.; Reda, R.M. Beta-Glucans and Mannan Oligosaccharides Enhance Growth and Immunity in Nile Tilapia. N. Am. J. Aquac. 2015, 77, 22–30. [Google Scholar] [CrossRef]
  18. Soltanian, S.; Stuyven, E.; Cox, E.; Sorgeloos, P.; Bossier, P. Beta-glucans as immunostimulant in vertebrates and invertebrates. Crit. Rev. Microbiol. 2009, 35, 109–138. [Google Scholar] [CrossRef] [PubMed]
  19. Ewaschuk, J.B.; Johnson, I.R.; Madsen, K.L.; Vasanthan, T.; Ball, R.; Field, C.J. Barley-derived β-glucans increases gut permeability, ex vivo epithelial cell binding to E. coli, and naïve T-cell proportions in weanling pigs. J. Anim. Sci. 2012, 90, 2652–2662. [Google Scholar] [CrossRef]
  20. Zhang, M.; Kim, J.A.; Huang, A.Y.C. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles. Front. Immunol. 2018, 9, 341. [Google Scholar] [CrossRef] [Green Version]
  21. Akdis, M.; Aab, A.; Altunbulakli, C.; Azkur, K.; Cota, R.A.; Crameri, R.; Duan, S.; Eiwegger, T.; Eljaszewicz, A.; Ferstl, R.; et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 2016, 138, 984–1010. [Google Scholar] [CrossRef] [Green Version]
  22. Stuyven, E.; Verdonck, F.; Van Hoek, I.; Daminet, S.; Duchateau, L.; Remon, J.P.; Goddeeris, B.M.; Cox, E. Oral administration of β-1,3/1,6-glucan to dogs temporally changes total and antigen specific IgA and IgM. Clin. Vaccine Immunol. 2010, 17, 281–285. [Google Scholar] [CrossRef] [Green Version]
  23. Day, M. Cats are not small dogs: Is there an immunological explanation for why cats are less affected by arthropod-borne disease than dogs? Parasites Vectors 2016, 9, 1–9. [Google Scholar] [CrossRef] [Green Version]
  24. Morris, K. The Feline Major Histocompatibility Complex. Univ. Syd. Undergrad. Res. J. 2009, 1, 1. [Google Scholar]
  25. Handl, S.; Dowd, S.E.; Garcia-Mazcorro, J.F.; Steiner, J.; Suchodolski, J.S. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol. Ecol. 2011, 76, 301–310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Tizard, I.R.; Jones, S.W. The microbiota regulates immunity and immunologic diseases in dogs and cats. Vet. Clin. N. Am. Small Anim. Pract. 2018, 48, 307–322. [Google Scholar] [CrossRef] [PubMed]
  27. Bradshaw, J.W.S. The Evolutionary Basis for the Feeding Behavior of Domestic Dogs (Canis familiaris) and Cats (Felis catus). J. Nutr. 2006, 136, 1927S–1931S. [Google Scholar] [CrossRef] [PubMed]
  28. Garcia-Mazcorro, J.F.; Ishaq, S.L.; Rodriguez-Herrera, M.V.; Garcia-Hernandez, C.A.; Kawas, J.R.; Nagaraja, T.G. Review: Are there indigenous Saccharomyces in the digestive tract of livestock animal species? Implications for health, nutrition and productivity traits. Animal 2019, 14, 22–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Cohn, D.A. Sensitivity to androgen. A possible factor in sex differences in the immune response. Clin. Exp. Immunol. 1979, 38, 218–227. [Google Scholar]
  30. McGraw, K.J.; Ardia, D.R. Sex differences in carotenoid status and immune performance in zebra finches. Evol. Ecol. Res. 2005, 7, 251–262. Available online: http://www.evolutionary-ecology.com/abstracts/v07/1807.html (accessed on 16 May 2020).
  31. Klein, S.; Flanagan, K. Sex differences in immune responses. Nat. Rev. Immunol. 2016, 16, 626–638. [Google Scholar] [CrossRef]
  32. Giefing-Kröll, C.; Berger, P.; Lepperdinger, G.; Grubeck-Loebenstein, B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell 2015, 14, 309–321. [Google Scholar] [CrossRef] [PubMed]
  33. Roved, J.; Westerdahl, H.; Hasselquist, D. Sex differences in immune responses: Hormonal effects, antagonistic selection, and evolutionary consequences. Horm. Behav. 2017, 88, 95–105. [Google Scholar] [CrossRef] [PubMed]
  34. Ahmed, S.A.; Penhale, W.J.; Talal, N. Sex Hormones, Immune Responses, and Autoimmune Diseases Mechanisms of Sex Hormone Action. Am. J. Pathol. 1985, 121, 531–551. [Google Scholar]
  35. Fish, E.N. The X-files in immunity: Sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008, 8, 737–744. [Google Scholar] [CrossRef] [PubMed]
  36. Schneider-Hohendorf, T.; Görlich, D.; Savola, P.; Kelkka, T.; Mustjoki, S.; Gross, C.C.; Owens, G.C.; Klotz, L.; Dornmair, K.; Wiendl, H.; et al. Sex bias in MHC I shaping of adaptive immunity. Proc. Natl. Acad. Sci. USA 2018, 115, 2168–2173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Rabies antibody levels (mean ± standard error) determined by the rapid fluorescent foci inhibition test (RFFIT) at 0, 21 and 42 days after rabies vaccination in previously-unvaccinated cats fed a control diet (Group A) or an identical diet supplemented with β-1,3-1,6-glucans (Group B), for 14 days prior to vaccination.
Figure 1. Rabies antibody levels (mean ± standard error) determined by the rapid fluorescent foci inhibition test (RFFIT) at 0, 21 and 42 days after rabies vaccination in previously-unvaccinated cats fed a control diet (Group A) or an identical diet supplemented with β-1,3-1,6-glucans (Group B), for 14 days prior to vaccination.
Vetsci 07 00118 g001
Table 1. Epidemiological data based on age and sex.
Table 1. Epidemiological data based on age and sex.
Group A (Placebo)Group B (Test)
Sex
Male9 (50%)9 (53%)
Female9 (50%)8 (47%)
Age in months
4–116 (33%)6 (35%)
12–238 (44%)7 (41%)
24–353 (17%)3 (18%)
36+1 (6%)1 (6%)

Share and Cite

MDPI and ACS Style

Byrne, J.; Knobel, D.; Moore, S.M.; Gatrell, S.; Butaye, P. The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats. Vet. Sci. 2020, 7, 118. https://doi.org/10.3390/vetsci7030118

AMA Style

Byrne J, Knobel D, Moore SM, Gatrell S, Butaye P. The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats. Veterinary Sciences. 2020; 7(3):118. https://doi.org/10.3390/vetsci7030118

Chicago/Turabian Style

Byrne, John, Darryn Knobel, Susan M. Moore, Stephanie Gatrell, and Patrick Butaye. 2020. "The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats" Veterinary Sciences 7, no. 3: 118. https://doi.org/10.3390/vetsci7030118

APA Style

Byrne, J., Knobel, D., Moore, S. M., Gatrell, S., & Butaye, P. (2020). The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats. Veterinary Sciences, 7(3), 118. https://doi.org/10.3390/vetsci7030118

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop